Human parvovirus B19 surveillance in patients with rash and fever from Belarus

Journal of Medical Virology

Volumn 84, Issue 6, 2012, Pages 973-978

  Yermalovich, Marina A ^a   Hübschen, Judith M ^b   Semeiko, Galina V ^a   Samoilovich, Elena O ^a   Muller, Claude P ^b  

^a Republican Research and Practical Center for Epidemiology and Microbiology   (Belarus)

^b LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

Epidemiology; Erythema infectiosum; Genotype; Phylogenetic analysis

Indexed keywords

IMMUNOGLOBULIN M;

ADULT; ARTICLE; BELARUS; CHILD; DISEASE SURVEILLANCE; FEVER; GENETIC ANALYSIS; GROUPS BY AGE; HUMAN; HUMAN PARVOVIRUS B19; MAJOR CLINICAL STUDY; MEASLES; PARVOVIRUS INFECTION; PHYLOGENY; PRESCHOOL CHILD; RASH; RUBELLA; SCHOOL CHILD; SCREENING TEST; SEQUENCE ANALYSIS; SERUM CHARACTERISTICS;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DISEASE OUTBREAKS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; EXANTHEMA; FEMALE; FEVER; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PARVOVIRUS B19, HUMAN; PHYLOGENY; PREGNANCY; PREVALENCE; REPUBLIC OF BELARUS; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

PARVOVIRUS; RUBELLA;

EID: 84859753176     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23294     Document Type: Article

References (32)

1. Anderson LJ. 1987. Role of parvovirus B19 in human disease. Pediatr Infect Dis J 6: 711- 718.
2. Broliden K, Tolfvenstam T, Norbeck O. 2006. Clinical aspects of parvovirus B19 infection. J Intern Med 260: 285- 304.
3. Candotti D, Etiz N, Parsyan A, Allain JP. 2004. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol 78: 12169- 12178.
4. Cohen BJ, Gandhi J, Clewley JP. 2006. Genetic variants of parvovirus B19 identified in the United Kingdom: Implications for diagnostic testing. J Clin Virol 36: 152- 155.
5. Davidkin I, Valle M, Peltola H, Hovi T, Paunio M, Roivainen M, Linnavuori K, Jokinen S, Leinikki P. 1998. Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children. J Infect Dis 178: 1567- 1570.
6. Enders M, Schalasta G, Baisch C, Weidner A, Pukkila L, Kaikkonen L, Lankinen H, Hedman L, Soderlund-Venermo M, Hedman K. 2006. Human parvovirus B19 infection during pregnancy-Value of modern molecular and serological diagnostics. J Clin Virol 35: 400- 406.
7. Gallinella G, Venturoli S, Manaresi E, Musiani M, Zerbini M. 2003. B19 virus genome diversity: Epidemiological and clinical correlations. J Clin Virol 28: 1- 13.
8. Goncalves G, Correia AM, Palminha P, Rebelo-Andrade H, Alves A. 2005. Reply to letter: Outbreaks caused by parvovirus B19 in three Portuguese schools. Euro Surveill 10: 121- 124.
9. Heegaard ED, Brown KE. 2002. Human parvovirus B19. Clin Microbiol Rev 15: 485- 505.
10. Heegaard ED, Panum Jensen I, Christensen J. 2001. Novel PCR assay for differential detection and screening of erythrovirus B19 and erythrovirus V9. J Med Virol 65: 362- 367.
11. Hokynar K, Norja P, Laitinen H, Palomaki P, Garbarg-Chenon A, Ranki A, Hedman K, Soderlund-Venermo M. 2004. Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests. J Clin Microbiol 42: 2013- 2019.
12. Hubschen JM, Mihneva Z, Mentis AF, Schneider F, Aboudy Y, Grossman Z, Rudich H, Kasymbekova K, Sarv I, Nedeljkovic J, Tahita MC, Tarnagda Z, Ouedraogo JB, Gerasimova AG, Moskaleva TN, Tikhonova NT, Chitadze N, Forbi JC, Faneye AO, Otegbayo JA, Charpentier E, Muller CP. 2009. Phylogenetic analysis of human parvovirus b19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J Clin Microbiol 47: 3735- 3738.
13. Ke L, He M, Li C, Liu Y, Gao L, Yao F, Li J, Bi X, Lv Y, Wang J, Hirsch ML, Li W. 2011. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers. Transfusion 51: 1909- 1918.
14. Kooistra K, Mesman HJ, de Waal M, Koppelman MH, Zaaijer HL. 2011. Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009. Vox Sang 100: 261- 266.
15. Mendonca MC, Ferreira AM, Santos MG, Oviedo EC, Bello MS, Siqueira MM, Maceira JM, von Hubinger MG, Couceiro JN. 2011. Genotyping of human parvovirus B19 in clinical samples from Brazil and Paraguay using heteroduplex mobility assay, single-stranded conformation polymorphism and nucleotide sequencing. Mem Inst Oswaldo Cruz 106: 502- 504.
16. Mossong J, Hens N, Friederichs V, Davidkin I, Broman M, Litwinska B, Siennicka J, Trzcinska A, VAND, P, Beutels P, Vyse A, Shkedy Z, Aerts M, Massari M, Gabutti G. 2008. Parvovirus B19 infection in five European countries: Seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect 136: 1059- 1068.
17. Nicolay N, Cotter S. 2009. Clinical and epidemiological aspects of parvovirus B19 infections in Ireland, January 1996-June 2008. Euro Surveill 14.
18. Opaleye OO, Fagbami AH, Lalremruata A, Kun JF. 2011. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria. J Med Virol 83: 710- 716.
19. Plummer FA, Hammond GW, Forward K, Sekla L, Thompson LM, Jones SE, Kidd IM, Anderson MJ. 1985. An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med 313: 74- 79.
20. Ramsay M, Reacher M, O'Flynn C, Buttery R, Hadden F, Cohen B, Knowles W, Wreghitt T, Brown D. 2002. Causes of morbilliform rash in a highly immunised English population. Arch Dis Child 87: 202- 206.
21. Sabella C, Goldfarb J. 1999. Parvovirus B19 infections. Am Fam Physician 60: 1455- 1460.
22. Sanabani S, Neto WK, Pereira J, Sabino EC. 2006. Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms. J Clin Microbiol 44: 604- 606.
23. Servant A, Laperche S, Lallemand F, Marinho V, De Saint Maur G, Meritet JF, Garbarg-Chenon A. 2002. Genetic diversity within human erythroviruses: Identification of three genotypes. J Virol 76: 9124- 9134.
24. Servey JT, Reamy BV, Hodge J. 2007. Clinical presentations of parvovirus B19 infection. Am Fam Physician 75: 373- 376.
25. Shackelton LA, Holmes EC. 2006. Phylogenetic evidence for the rapid evolution of human B19 erythrovirus. J Virol 80: 3666- 3669.
26. Siennicka J, Trzcinska A. 2010. Comparison of three enzyme immunoassays used to detect human parvovirus B19-specific IgM antibodies in sera of people suspected of measles. Med Sci Monit 16: BR154- BR159.
27. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596- 1599.
28. Toan NL, Duechting A, Kremsner PG, Song le H, Ebinger M, Aberle S, Binh VQ, Duy DN, Torresi J, Kandolf R, Bock CT. 2006. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. J Gen Virol 87: 2941- 2949.
29. Urban C, Lackner H, Muller E, Benesch M, Strenger V, Sovinz P, Schwinger W. 2011. Stem cell transplantation in 6 children with parvovirus B19-induced severe aplastic anaemia or myelodysplastic syndrome. Klin Padiatr 223: 332- 334.
30. Vianna RA, de Oliveira SA, Camacho LA, Knowles W, Brown D, Pereira AC, Velarde LG, Siqueira MM. 2008. Role of human herpesvirus 6 infection in young Brazilian children with rash illnesses. Pediatr Infect Dis J 27: 533- 537.
31. Young NS, Brown KE. 2004. Parvovirus B19. N Engl J Med 350: 586- 597.
32. Zaaijer HL, Koppelman MH, Farrington CP. 2004. Parvovirus B19 viraemia in Dutch blood donors. Epidemiol Infect 132: 1161- 1166.